Adverse Drug Reaction News and Research

RSS
Interferon retreatment of chronic hepatitis C may be harmful

Interferon retreatment of chronic hepatitis C may be harmful

Vaccine confidence: an interview with Dr Heidi Larson

Vaccine confidence: an interview with Dr Heidi Larson

Alcohol and antibiotics: an interview with Dr Randall

Alcohol and antibiotics: an interview with Dr Randall

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Bowel cancer and GIST patients could benefit from novel oral drug

Bowel cancer and GIST patients could benefit from novel oral drug

Advanced breast cancer that has spread to the brain could be treated with drug combination

Advanced breast cancer that has spread to the brain could be treated with drug combination

New neuroprotective agent for stroke patients potentially found

New neuroprotective agent for stroke patients potentially found

MHRA approves Sucampo’s AMITIZA to treat chronic idiopathic constipation in the U.K.

MHRA approves Sucampo’s AMITIZA to treat chronic idiopathic constipation in the U.K.

Dengue vaccine breakthrough

Dengue vaccine breakthrough

Phase III data for Suvorexant, an investigational insomnia medicine, announced

Phase III data for Suvorexant, an investigational insomnia medicine, announced

UC San Diego, iSAEC partner to study genetics of drug induced renal injury

UC San Diego, iSAEC partner to study genetics of drug induced renal injury

Medication reconciliation in hospitals: an interview with Dr. Leonard Feldman

Medication reconciliation in hospitals: an interview with Dr. Leonard Feldman

Training nurse-pharmacist teams to track discrepancies between patients medications at home and in hospital may reduce conflicts

Training nurse-pharmacist teams to track discrepancies between patients medications at home and in hospital may reduce conflicts

Breast cancer drug bevacizumab (Avastin): an interview with Dr Anna Dorothea Wagner

Breast cancer drug bevacizumab (Avastin): an interview with Dr Anna Dorothea Wagner

Insomnia: an interview with Dr Darryle Schoepp

Insomnia: an interview with Dr Darryle Schoepp

TB combination drug trials progress

TB combination drug trials progress

Preventable hospital deaths: An interview with Dr Helen Hogan

Preventable hospital deaths: An interview with Dr Helen Hogan

Investigational Insomnia Medicine from Merck improved patients’ ability to fall and stay asleep according to new phase III Data

Investigational Insomnia Medicine from Merck improved patients’ ability to fall and stay asleep according to new phase III Data

Personalized medicine and the Human Genome Project

Personalized medicine and the Human Genome Project

Increasing Use of Smart Pumps to help drive down “Never Events”

Increasing Use of Smart Pumps to help drive down “Never Events”